Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL6282631

CC(C)(C)c1ccccn1.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 2/20 0.41
AHR P35869 1/20 0.40
ABCC9 O60706 1/20 0.39
ABCC8 Q09428 1/20 0.39
KCNJ11 Q14654 1/20 0.39
KCNJ8 Q15842 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
POLB P06746 1/20 0.38
HSD11B1 P28845 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
PTGS2 P35354 2/20 0.37
LMNA P02545 2/20 0.37
CETP P11597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL28203196 0.86 SMN1; SMN2 (0.48) SMN1; SMN2L3MBTL1ALDH1A1KDM4EAHR
SCHEMBL29080 0.81 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1ALDH1A1KDM4EAHR
SCHEMBL29349628 0.81 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1ALDH1A1KDM4EAHR
Trifluoromethanesulfonic Acid SCHEMBL7149550 0.80 PGK1 (0.44) SMN1; SMN2L3MBTL1ALDH1A1KDM4EABCC9
SCHEMBL18263711 0.80 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1ALDH1A1KDM4ENPC1
Ammonia Solution, Strong SCHEMBL7412270 0.79 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1ALDH1A1KDM4EAHR
SCHEMBL29016490 0.79 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1ALDH1A1KDM4EAHR
Iodide SCHEMBL2177798 0.79 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1ALDH1A1KDM4EAHR
SCHEMBL29798224 0.79 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1ALDH1A1KDM4EAHR
SCHEMBL6652864 0.79 SMN1; SMN2 (0.53) SMN1; SMN2L3MBTL1ALDH1A1KDM4EAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6974870-B2 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses BOEHRINGER INGELHEIM PHAMACEUTICALS, INC. (US) 2005-12-13 US disclosed
US-20040180922-A1 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180922-A1 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses NFKBIA, IKBKB, CHUK SMN1; SMN2 3870/4885L3MBTL1 3632/4885ALDH1A1 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.